ArticleFrontiers in neurology2025
Correlation of telomere length and DNA damage markers with severity and associated depressive states in patients with OSAS.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Investigation of the correlation of peripheral blood leukocyte relative telomere length (RTL) and DNA damage markers with severity and related depressive states in patients with obstructive sleep apnea syndrome (OSAS). Methods: A total of 110 OSAS patients admitted to the hospital between January 2023 and December 2024 were selected. Based on examination results, the OSAS patients were divided into the mild to moderate and the severe groups. Additionally, 45 healthy volunteers who voluntarily participated in the study during the same period were included as a healthy control group. RTL and DNA damage markers [phosphorylated histone H2AX (γH2AX), 8-hydroxydeoxyguanosine (8-OHdG)] of the three groups were compared among the three groups. The Hamilton Depression Scale (HAMD) was used to assess the depressive status of OSAS patients, who were further categorized into the depressed group (HAMD score >7) and non-depressed group (HAMD score ≤7) based on the severity of depression. The correlation of RTL and the above markers with the severity of the disease of OSAS patients and their HAMD scores was analyzed by Results: The RTL values of patients in the severe and the mild to moderate group were significantly lower than those of the healthy control group with higher levels of γH2AX and 8-OHdG, and the differences of three indexes between the severe group and the mild to moderate group registered statistical significance ( Conclusion: RTL, γH2AX, and 8-OHdG exert an important role in assessing the severity of disease in OSAS patients. Besides, there exists a significant correlation between the three indexes and the depressive state of patients, boasting a good predictive efficacy for their secondary depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.